The addition of aminoacids and phosphate to hemodiafiltration solutions in newborns with hyperammonemic coma.
A child with carbamyl-phosphate-synthetase defect who died after prolonged continuous hemodiafiltration in deep coma proved to have high aminoacid losses despite aminoacid infusion. We think that this results from high small-solute clearance during hemodialysis. In order to prevent these inevitable catabolic side-effects we decided to add aminoacids to the dialysate and substitution fluid in these children with metabolic diseases. Additionally we propose to add phosphate in order to avoid depletion. The aim is to achieve anabolic or at least non-catabolic hemodiafiltration.
Fründ
S
S
Westfälische Wilhelms-Universität, Pediatric University Hospital, Münster, Germany.
Kuwertz-Bröking
E
E
Koch
H G
HG
Bulla
M
M
Harms
E
E
D000596:Amino Acids / Q000627:therapeutic use*; D000641:Ammonia / Q000097:blood*; D002222:Carbamoyl-Phosphate Synthase (Ammonia) / Q000172:deficiency; D003128:Coma / Q000097:blood / Q000209:etiology* / Q000628:therapy*; D015314:Dialysis Solutions / Q000627:therapeutic use*; D017809:Fatal Outcome; D005260:Female; D017583:Hemodiafiltration / Q000379:methods*; D006801:Humans; D007231:Infant, Newborn; D010710:Phosphates / Q000627:therapeutic use*
D000596:Amino Acids; D015314:Dialysis Solutions; D010710:Phosphates; D000641:Ammonia; D002222:Carbamoyl-Phosphate Synthase (Ammonia)